Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 1;20(11):1630-1633.
doi: 10.2215/CJN.0000000733. Epub 2025 Apr 16.

Vascular Calcification and CKD: Challenges, Emerging Targets, and Future Perspectives

Lucie Fernandez  1 , Julie Klein
Affiliations

Vascular Calcification and CKD: Challenges, Emerging Targets, and Future Perspectives

Lucie Fernandez et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: CKD; vascular calcification.

PubMed Disclaimer

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/CJN/C261.

References

    1. Hutcheson JD, Goettsch C. Cardiovascular calcification heterogeneity in chronic kidney disease. Circ Res. 2023;132(8):993–1012. doi: 10.1161/CIRCRESAHA.123.321760 - DOI - PMC - PubMed
    1. Pan W, Jie W, Huang H. Vascular calcification: molecular mechanisms and therapeutic interventions. MedComm (2020). 2023;4(1):e200. doi: 10.1002/mco2.200 - DOI - PMC - PubMed
    1. Xu C, Smith ER, Tiong MK, Ruderman I, Toussaint ND. Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials. J Am Soc Nephrol. 2022;33(5):1011–1032. doi: 10.1681/ASN.2021101327 - DOI - PMC - PubMed
    1. Bressendorff I Hansen D Schou M, et al. The effect of magnesium supplementation on vascular calcification in CKD: a randomized clinical trial (MAGiCAL-CKD). J Am Soc Nephrol. 2023;34(5):886–894. doi: 10.1681/ASN.0000000000000092 - DOI - PMC - PubMed
    1. Amaya-Garrido A Brunet M Buffin-Meyer B, et al. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease. Sci Transl Med. 2023;15(712):eabn5939. doi: 10.1126/scitranslmed.abn5939 - DOI - PubMed

Associated data

LinkOut - more resources